ConductScience.org, home

Paper39584

Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents.

Ariniego R and 3 others. Br Heart J, 1979. Cited by 64 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents. Papers, record 39584. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39584

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents.
PubMed
Journal
Br Heart J
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
3.37
iCite
Revised in PubMed
2019-05-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ariniego RR
2Waagstein FF
3Mombay BB
4Hjalmarson AA

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AgonistsMajor topic
HemodynamicsMajor topic
MetoprololMajor topic
Myocardial InfarctionMajor topic
PropanolaminesMajor topic
Acute Disease
Adult
Aged
Heart
Heart Rate
Humans
Middle Aged
Myocardial Contraction
Stimulation, Chemical

Source PubMed

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,097,925Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.N Engl J Med1975https://conductscience.org/library/papers/1097925PubMed
21,103,909Clinical experience with use of ultrasound sphygmomanometer.Br Heart J1975https://conductscience.org/library/papers/1103909PubMed
31,115,371Accuracy of the stroke index as determined by the transthoracic electrical impedance method.Anesthesiology1975https://conductscience.org/library/papers/1115371PubMed
41,155,341Hemodynamic effect of dobutamine in patients with severe heart failure.Am J Cardiol1975https://conductscience.org/library/papers/1155341PubMed
5203,177Plasma norepinephrine in congestive heart failure.Am J Cardiol1978https://conductscience.org/library/papers/203177PubMed
622,823Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists.Naunyn Schmiedebergs Arch Pharmacol1977https://conductscience.org/library/papers/22823PubMed
725,015Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptors.Am Heart J1978https://conductscience.org/library/papers/25015PubMed
83,098Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction.Acta Med Scand Suppl1976https://conductscience.org/library/papers/3098PubMed
933,811Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in man.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/33811PubMed
10350,252The use of dobutamine in myocardial infarction for reversal of the cardiodepressive effect of metoprolol.Br J Clin Pharmacol1978https://conductscience.org/library/papers/350252PubMed
114,080Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests.Br Heart J1976https://conductscience.org/library/papers/4080PubMed
124,143,986The failing myocardium. I. Drug management.Med Clin North Am1973https://conductscience.org/library/papers/4143986PubMed
134,153,071Special article. The role of beta-adrenergic blockade in myocardial infarction.Prog Cardiovasc Dis1974https://conductscience.org/library/papers/4153071PubMed
144,294,053Effects of adrenergic receptor activation and blockade on the systolic preejection period, heart rate, and arterial pressure in man.J Clin Invest1967https://conductscience.org/library/papers/4294053PubMed
154,395,870Beta adrenergic blockade in the circulatory regulation of hyperkinetic states.Am J Cardiol1971https://conductscience.org/library/papers/4395870PubMed
164,451,589Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol.Br Heart J1974https://conductscience.org/library/papers/4451589PubMed
174,746,723Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs.Circ Res1973https://conductscience.org/library/papers/4746723PubMed
184,826,937In vivo analysis of adrenergic receptor activity of dobutamine.Circ Res1974https://conductscience.org/library/papers/4826937PubMed
194,994,214Accuracy of an automated ultrasound blood pressure monitor.Curr Ther Res Clin Exp1971https://conductscience.org/library/papers/4994214PubMed
205,041,440Haemodynamic effects of isoprenaline in acute myocardial infarction.Br Heart J1972https://conductscience.org/library/papers/5041440PubMed

See all 29 references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
7,295,483The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7295483PubMed
7,253,539Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.Klin Wochenschr1981https://conductscience.org/library/papers/7253539PubMed
6,833,622Amrinone--promising innovation for treatment of the failing heart.Intensive Care Med1983https://conductscience.org/library/papers/6833622PubMed
6,628,515Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6628515PubMed
6,152,394Arrhythmogenic dose of acetylstrophanthidin unchanged by beta-sympathomimetics in conscious dogs.Basic Res Cardiol1984https://conductscience.org/library/papers/6152394PubMed
6,151,806
Apparent superiority of H2-receptor stimulation and simultaneous beta-blockade over conventional treatment with beta-sympathomimetic drugs in post-acute myocardial infarction: cardiac effects of impromidine--a new specific H2-receptor agonist-in the surviving catecholamine-insensitive myocardium.
Agents Actions1984https://conductscience.org/library/papers/6151806PubMed
6,148,979Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.Br J Pharmacol1984https://conductscience.org/library/papers/6148979PubMed
6,132,344beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.Naunyn Schmiedebergs Arch Pharmacol1982https://conductscience.org/library/papers/6132344PubMed
6,121,566Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.Br Heart J1982https://conductscience.org/library/papers/6121566PubMed
6,121,296Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.Naunyn Schmiedebergs Arch Pharmacol1982https://conductscience.org/library/papers/6121296PubMed
6,108,221Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/6108221PubMed
6,108,219Immediate haemodynamic effects of prenalterol, a new adrenergic beta-1-receptor agonist, in healthy volunteers.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/6108219PubMed
6,107,091Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.Br Heart J1980https://conductscience.org/library/papers/6107091PubMed
1,280,115The inhibitory GTP-binding protein (Gi) regulates the agonistic property of beta-adrenergic ligands in isolated rat adipocytes. Evidence for a priming effect of cyclic AMP.Biochem J1992https://conductscience.org/library/papers/1280115PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39584

GET https://conductscience.org/api/papers/v1/39584/references?page=2